Evidence map›Paper›PMID 22920495›Full record

ArticleThe Journal of allergy and clinical immunology2012

Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation.

David F Choy, Daniel K Hsu, Dhaya Seshasayee, Maxwell A Fung, Zora Modrusan, Flavius Martin, Fu-Tong Liu, Joseph R Arron

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in The Journal of allergy and clinical immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02317276 (A Study in Atopic Dermatitis to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid), which is not on this map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02317276 phase4terminatednot on this mapstarted 2014, after this paper: background citation

A Study in Atopic Dermatitis to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

TypeinterventionalSponsorUniversity of California, San FranciscoRan2014 to 2017Enrolled11ConditionsDermatitis, AtopicArmsTriamcinolone 0.1%
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Neutrophils in Atopic Dermatitis.Clinical reviews in allergy & immunology · 2024
    Review
  14. Article
  15. Science advances · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

David F ChoyDepartment of Immunology, Tissue Growth, and Repair Biomarker Discovery, Genentech, South San Francisco, CA, USA.
Daniel K Hsu
Dhaya Seshasayee
Maxwell A Fung
Zora Modrusan
Flavius Martin
Fu-Tong Liu
Joseph R Arron
Institute of Biomedical Sciences, Academia Sinica · TWUniversity of California, Davis · US

Funding

IGE BINDING PROTEIN--A MULTIFUNCTIONAL ANIMAL LECTINR01AI020958 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI LIU, FU-TONG · 1985 to 2008
$2.0M
Galectin-3 in regulation of allergic skin inflammationR01AR056343 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LIU, FU-TONG · 2010 to 2014
$1.7M
Regulation of Skin Wound Epithelialization by Galectin-3R21AR053116 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LIU, FU-TONG · 2007 to 2008
$356k
NIAID NIH HHS R01 AI020958NIAID NIH HHS R01 AI20958NIAMS NIH HHS R01 AR056343NIAMS NIH HHS R01AR056343NIAMS NIH HHS R21 AR053116
6 · The paper itself

Abstract

backgroundAtopic dermatitis (AD) and psoriasis are common inflammatory diseases canonically described as involving distinct T(H) polarization and granulocytic infiltration. Acute AD lesions are associated with T(H)2 and eosinophilic inflammation, whereas psoriatic lesions are associated with T(H)1/T(H)17 and neutrophilic inflammation. Despite intensive investigation, these pathways remain incompletely understood in vivo in human subjects.

objectiveUsing AD and psoriatic lesional skin as exemplar T(H)2 and T(H)1/T(H)17 diseased tissue, we sought to clarify common and unique molecular and pathophysiologic features in inflamed skin with different types of inflammatory polarization.

methodsWe conducted gene expression microarray analyses to identify distinct and commonly dysregulated expression in AD (based on Hanifin and Rajka criteria) and psoriatic lesions. We defined gene sets (GSs) as comprising genes encoding cytokines, chemokines, and growth factors that were uniquely or jointly dysregulated in patients with AD and those with psoriasis and calculated aggregate GS expression scores for lesional skin of patients with these dermatoses and healthy control skin.

resultsThe atopic dermatitis gene set (AD-GS) score correlated with systemic and local measures of allergic inflammation, including serum IgE levels, blood eosinophil counts, and tissue eosinophil counts. Unexpectedly, genes encoding neutrophil chemoattractants among the common GS were highly expressed in AD lesional skin. Hematoxylin and eosin and immunohistochemical analyses showed the numbers of neutrophils in AD lesional skin were comparable with those in psoriatic lesional skin, and both were correlated with the extent of expression of neutrophil chemoattractant genes.

conclusionThese data are evidence that neutrophilic inflammation is a feature of lesional AD pathology comorbid with allergic inflammation.

Indexed as

AdultAgedCell MovementChemokinesDermatitis, AtopicFemaleHumansImmunoglobulin EInflammation MediatorsMaleMicroarray AnalysisMiddle AgedNeutrophilsPsoriasisSkinTh1-Th2 BalanceChemokinesImmunoglobulin EInflammation Mediators

Identifiers

PMID22920495
PMCPMC3511596
OpenAlexW2025475332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.